BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1353 related articles for article (PubMed ID: 19325148)

  • 1. Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration.
    Kwon SM; Suzuki T; Kawamoto A; Ii M; Eguchi M; Akimaru H; Wada M; Matsumoto T; Masuda H; Nakagawa Y; Nishimura H; Kawai K; Takaki S; Asahara T
    Circ Res; 2009 Apr; 104(8):969-77. PubMed ID: 19325148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.
    Lee JH; Lee SH; Yoo SY; Asahara T; Kwon SM
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1622-34. PubMed ID: 23640491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization.
    Kwon SM; Lee YK; Yokoyama A; Jung SY; Masuda H; Kawamoto A; Lee YM; Asahara T
    J Mol Cell Cardiol; 2011 Sep; 51(3):308-17. PubMed ID: 21557947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy.
    Herrler T; Leicht SF; Huber S; Hermann PC; Schwarz TM; Kopp R; Heeschen C
    J Vasc Res; 2009; 46(4):333-46. PubMed ID: 19142013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lnk deletion reinforces the function of bone marrow progenitors in promoting neovascularization and astrogliosis following spinal cord injury.
    Kamei N; Kwon SM; Alev C; Ishikawa M; Yokoyama A; Nakanishi K; Yamada K; Horii M; Nishimura H; Takaki S; Kawamoto A; Ii M; Akimaru H; Tanaka N; Nishikawa S; Ochi M; Asahara T
    Stem Cells; 2010 Feb; 28(2):365-75. PubMed ID: 19859984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue.
    Duan H; Cheng L; Sun X; Wu Y; Hu L; Wang J; Zhao H; Lu G
    Thromb Haemost; 2006 Dec; 96(6):807-15. PubMed ID: 17139377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases.
    Yoon CH; Hur J; Park KW; Kim JH; Lee CS; Oh IY; Kim TY; Cho HJ; Kang HJ; Chae IH; Yang HK; Oh BH; Park YB; Kim HS
    Circulation; 2005 Sep; 112(11):1618-27. PubMed ID: 16145003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia.
    Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW
    Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy.
    Foubert P; Matrone G; Souttou B; Leré-Déan C; Barateau V; Plouët J; Le Ricousse-Roussanne S; Lévy BI; Silvestre JS; Tobelem G
    Circ Res; 2008 Sep; 103(7):751-60. PubMed ID: 18723447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis.
    Sbaa E; Dewever J; Martinive P; Bouzin C; Frérart F; Balligand JL; Dessy C; Feron O
    Circ Res; 2006 May; 98(9):1219-27. PubMed ID: 16601228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
    Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
    Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
    Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
    Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization.
    O E; Lee BH; Ahn HY; Shin JC; Kim HK; Kim M; Park IY; Park YG; Joe YA
    FASEB J; 2011 Jan; 25(1):159-69. PubMed ID: 20852063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
    Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.
    Takahashi T; Kalka C; Masuda H; Chen D; Silver M; Kearney M; Magner M; Isner JM; Asahara T
    Nat Med; 1999 Apr; 5(4):434-8. PubMed ID: 10202935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.
    Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells.
    Huang PH; Chen YH; Wang CH; Chen JS; Tsai HY; Lin FY; Lo WY; Wu TC; Sata M; Chen JW; Lin SJ
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1179-84. PubMed ID: 19461050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.